YOUR GO-TO CRO for PRECLINICAL EEG
Home » About Us
Unleash the Potential of Preclinical EEG to Accelerate CNS Drug Discovery
SynapCell is an innovative preclinical CNS CRO specializing in translational in vivo EEG. As forerunners in this field, with 20 years’ experience in preclinical EEG, SynapCell is driven by scientific excellence and innovation, providing drug developers with decision-making capabilities to identify and test their most promising candidates. The end goal is to accelerate the discovery of new treatments not only for Epilepsy but also for other major brain pathologies such as movement disorders, psychiatric disorders and neurodegenerative disorders.
At SynapCell, we offer a wide range of preclinical EEG services, from customized in vivo electrophysiology solutions to full-service solutions, acting as customers’ remote preclinical EEG laboratory. Beyond data, our team provides comprehensive support and assistance throughout the design, execution and analysis of studies, transforming data into valuable, meaningful predictive information to allow immediate decision-making. As a key partner in CNS drug discovery, at SynapCell we have evaluated a wide range of compounds for biotechs and major pharma companies worldwide.
Not Just Another Preclinical CNS CRO
We don’t just provide data. We are your partners from conceptualization to conclusion, working with us means collaborating with a group who are driven by customer satisfaction and scientific excellence. Building on decades of expertise and experience in preclinical translational EEG, we provide our customers with end-to-end support and advice to generate valuable decision-making information. Our goal is to provide objective results to accelerate the search for new therapeutic treatments for brain diseases, and help select the best among your potential candidates.
Unique Preclinical EEG Expertise to Accelerate Drug Assessment
At SynapCell, as pioneers in preclinical EEG for the study of Central Nervous System (CNS) responses to active molecules and treatments, we have developed unique know-how in our field of expertise. For 20 years, and thanks to our growing R&D team, we have been perfecting our methods and technologies, and continue to do so to remain at the cutting edge and to provide our customers with the high quality and scientific excellence they deserve.
Cue®, SynapCell’s proprietary and predictive translational in vivo EEG platform, allows our sponsors to predict in-human efficacy of drug candidates at the preclinical stage. To effectively assess the impact of a molecule on the brain, Cue® combines all SynapCell’s know-how and expertise in preclinical EEG: neuroscience, pharmacology, brain surgery, signal recording and analysis.
Our experienced staff conduct precise surgical interventions and electrode implantations to allow EEG recordings. We work with translational models, targeting various brain structures while adhering to ethical guidelines, and have high-level expertise in preclinical brain surgery.
Recording and processing preclinical EEGs to track CNS disorders hold no secrets for us. We use advanced in vivo techniques, proprietary deep-learning platforms, and translational EEG biomarkers to provide precise, reproducible data, ensuring accurate assessment of drug efficacy and phenotyping of rodent models.
Preclinical EEG analysis requires real expertise due to signal complexity, model specificity and the translational nature of the research. Knowledge from preclinical models must be interpreted as potential clinical outcomes. SynapCell’s experts meet all these challenges, ensuring accurate interpretation of data and reliable assessment of drug efficacy.
What Makes Us Different?
Grenoble is often referred to as one of France’s leading innovation and technology hubs. Located in the heart of the French Alps, its top-level laboratories have produced many innovations in the fields of medical technology, diagnostics, nanotechnology, semiconductors, AI, life sciences and neuroscience.
20 year's expertise in precLinical EEG
SynapCell has developed unique know-how in EEG-based in vivo preclinical tests. Our experts excel in the fields of neuroscience, pharmacology, brain surgery, and EEG signal processing and analysis.
STRONG
REPUTATION
We have been working for decades with a wide range of companies, from major pharmacology firms to biotech companies, providing preclinical EEG expertise. 100% of our customers would recommend SynapCell!
Our customers are located all over the world, in Europe, North America and Asia. We work in all time zones.
CONSTANT
INNOVATION
SynapCell has been a pioneer in the field of preclinical EEG for CNS drug discovery. We have our own R&D center and invest heavily to remain at the cutting edge and offer the best services.
Adaptability
is key
We understand that science – biology in particular – can be challenging; our teams’ high flexibility allows them to adapt to your ongoing study.
We value discussions with clients throughout their study, to ensure that we can adapt our approach in line with necessary and important changes.
Customer satisfaction IS a top priority
We design your trial to suit your needs, providing comprehensive support and assistance from start to finish. For each collaboration, we discuss needs with the client, including time and resource constraints, to develop and fine-tune the best corresponding study design.
A great team
to work with!
Our customers say that our teams are a pleasure to work with. You can expect: swift answers, transparent collaboration and great fun!
“I would like to express my sincere gratitude for the outstanding collaboration we’ve shared over the past years. It has truly been a terrific experience working with you and we greatly appreciate the quality of the science performed at SynapCell.”
Nina DEDIC,
Former Sr. Director and Head of CNS Pharmacology, Sumitomo Pharma America
Let's Talk About Your Research Project!
More than a CRO, we see ourselves as a team of collaborators – we are your dream neuroscience team specialized in preclinical EEG! We don’t just produce data, we are your partners from conceptualization to conclusion. We translate raw EEG data into meaningful, clinically-relevant endpoints, delivering clear insights to allow data-based decision-making. Choose SynapCell, a leading preclinical CNS-specialized CRO for cutting-edge EEG expertise combined with an irresistible touch of fun.
News & Events
PRESS RELEASE
SynapCell and the University of Utah Celebrate the 10-year Anniversary of their Collaboration on Anti-Seizure Medications.
NEW!
AMYGDALA KINDLING MODEL
Choose our Amygdala Kindling model to test compounds targeting focal-to-bilateral tonic-clonic seizures. Choosing the right model for the appropriate type of epilepsy seizures is key to the effective discovery of ASMs.
NEW!
SLEEP & VIGILANCE STATES
Discover SynapCell’s new preclinical EEG capabilities for sleep and vigilance states, and gain additional insights to characterize compound effects.